Auftragserfassung
Switzerland
AuftragsverfolgungKontakt
D-(-)-Luciferin ≥98% chemiluminescent luciferase substrate

D-(-)-Luciferin ≥98% chemiluminescent luciferase substrate

 :   Abcam
D-(-)-Luciferin ≥98% chemiluminescent luciferase substrate
 :  Abcam
 
D-(-)-Luciferin ≥98% chemiluminescent luciferase substrate

 

 

Cell-permeable chemiluminescent luciferase substrate. Emits lights upon oxidative decarboxylation in the presence of ATP. Provides a bioluminescent signal for cellular ATP levels in vivo. Water soluble analogs are D-Luciferin potassium salt and D-Luciferin sodium salt.

Caution: All products are FOR RESEARCH USE ONLY. PRODUCTS ARE NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES. Customer is granted a limited use non-exclusive licence for its own internal research. Any control manufacturer supplies with a Product is limited to use only to validate the relevant Product. By using the Product, Customers agree not to attempt to reverse engineer or otherwise perform any compositional, structural, functional or other analyses directed to learning the methodology, formulae, sequences, processes, make-up or production of any of the Products or portions thereof.

 :  D-Luciferin, (S)-2-(6-Hydroxybenzo[d]thiazol-2-yl)-4,5-dihydrothiazole-4-carboxylic acid
  •  :2591-17-5
  •  :280,3 g/mol
 

 

  • Constituents::
    99,53% (S)-4,5-dihydro-2-(6-hydroxybenzothiazol-2-yl)thiazole-4-carboxylic acid
Product Family Options

 

  •  
     
  •    
       
    1 * 5 mg
    1 * 5 mg - SFr. 105.00
    SFr. 105.00
    1 * 5 mg
       SFr. 105.00

     
    Marketsource
    Marketsource
  •    
       
    1 * 50 mg
    1 * 50 mg - SFr. 280.00
    SFr. 280.00
    1 * 50 mg
       SFr. 280.00

  •    
       
    1 * 10 mg
    1 * 10 mg - SFr. 135.00
    SFr. 135.00
    1 * 10 mg
       SFr. 135.00

Recommendations

Recommendations will be personalized based on your shopping preferences only if you have given your consent by enabling "Enhance my Shopping Experience" on the "Personal Info page".

Otherwise, you will receive generic recommendations.